换一批Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
第一作者：
Peter M,Aupperle
第一单位：
Division of Geriatric Psychiatry, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, NJ, USA. aupperpm@umdnj.edu
作者：
医学主题词
投药, 口服(Administration, Oral);老年人(Aged);老年人, 80以上(Aged, 80 and over);阿尔茨海默病(Alzheimer Disease);认知障碍(Cognition Disorders);剂量效应关系, 药物(Dose-Response Relationship, Drug);女(雌)性(Female);人类(Humans);男(雄)性(Male);精神状态检查表(Mental Status Schedule);神经保护药(Neuroprotective Agents);神经心理学测验(Neuropsychological Tests);医护疗养所(Nursing Homes);苯氨基甲酸酯类(Phenylcarbamates);前瞻性研究(Prospective Studies);疾病严重程度指数(Severity of Illness Index);治疗结果(Treatment Outcome)
DOI
10.1185/030079904125004204
PMID
15462693
发布时间
2015-11-19
- 浏览6
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
